Edmar Ferreira talks with Jacob Vogan, co-founder and Chief Scientific Officer of CB Therapeutics, where he designs and leads large projects to engineer microorganisms to produce high-value molecules, both natural and new-to-nature, for use in therapeutics, nutraceuticals, animal-free food, and more.